·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊÆ÷ÀÎÆ®¸ôTVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ´Ù»êÁ¦¾à, 360¾ï ±Ô¸ð ¸ß½ÃÄÚ ¼öÃâ °è¾à ±â»çÀÔ·Â : 20.11.18 11:59:05 0 °¡ ÇÃÄ£Ãß°¡ Neolpharma Group°ú º»Å¼º °íÇù¾Ð¾à 2Á¾ °ø±Þ Á¦ÈÞ ÇöÁö ÀÓ»ó µî °ÅÃÄ 2022³â Ãâ½Ã Àü¸Á [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] ´Ù»êÁ¦¾àÀÌ 360¾ï ±Ô¸ð ¸ß½ÃÄÚ ¼öÃâ °è¾àÀ» ü°áÇß´Ù. 18ÀÏ È¸»ç¿¡ µû¸£¸é ´Ù»êÁ¦¾àÀº ¸ß½ÃÄÚ Neolpharma Group°ú º»Å¼º°íÇ÷¾Ð Ä¡·á¿¡ »ç¿ëµÇ´Â Ç÷¾Ð°ÇÏÁ¦ 'ÇÁ¸®ÅÙ¼ÇÇ÷¯½ºÁ¤'°ú 'Æ®À©¾×Æ®Á¤' ¼öÃâ °è¾àÀ» ¸Î¾ú´Ù. ´Ù»êÁ¦¾àÀº ÇØ´ç Á¦Ç°Àº ÇöÁö Çã°¡ÈÄ 5³â°£ Neolpharma Group¿¡ °ø±ÞÇÑ´Ù. Ãâ½Ã ½ÃÁ¡Àº ¸ß½ÃÄÚ ÇöÁö ÀÓ»ó µî Çã°¡ ÀýÂ÷¸¦ °ÅÃÄ 2022³â °æÀÌ´Ù. °è¾à ±Ý¾×Àº 3250¸¸ ´Þ·¯(360¾ï¿ø) ±Ô¸ð´Ù. Neolpharma GroupÀº ¼ø¼ö ¸ß½ÃÄÚ ÀÚº» ¼³¸³È¸»ç·Î ¸ß½ÃÄÚ Á¤ºÎ ÀÔÂû Á¶´Þ 2À§ ±â¾÷ÀÌ´Ù. ¸ß½ÃÄÚ ¿Ü ¹Ì±¹, Áß³²¹Ì ±¹°¡¸¦ ´ë»óÀ¸·Î ¼öÃâÀ» ÁøÇàÇÏ°í ÀÖ´Ù. ÁÖ»çÁ¦ »ý»ê ¼³ºñ´Â ¾Æ¸Þ¸®Ä« ´ë·ú ³» ÃÖ´ë ±Ô¸ð¸¦ º¸À¯ÇÏ°í ÀÖ´Ù. ȸ»ç °ü°èÀÚ´Â "Áß³²¹Ì ±³µÎº¸ÀÎ ¸ß½ÃÄÚ¸¦ È®º¸ÇØ µ¿³²¾Æ µî ±âÁ¸ Áö¿ª¿¡ ÀÌ¾î ¼öÃâ È®´ë°¡ ±â´ëµÈ´Ù"°í ¸»Çß´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ¢ß¾ÖÀÓ½º¹ÙÀÌ¿À»çÀ̾𽺠RA Manager ä¿ë ¹Ù·Î°¡±â RA/PV Manager (°úÀå±Þ ÀÌ»ó) ¸ðÁý ¹Ù·Î°¡±â (Sr.) Medical & Scientific Relations ¹Ù·Î°¡±â º¹»ê³ªÀ̽º ºÎ»ê°ü¸®¾à»ç (ºÎ»êÅëÇÕ¹°·ù¼¾ÅÍ) ¹Ù·Î°¡±â [±¤µ¿Á¦¾à] Ç°Áú°¨»çÆÀ Á¦Á¶°ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â [HLBÁ¦¾à] ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â ÀǾàÇ°Àç°í ÀÔÃâ°í¹× Àç°í°ü¸®»ç¿ø¸ðÁý ¹Ù·Î°¡±â [ÇÏ¿ìÅõ¾à] ºê·£µå/Ç÷§Æû ¿î¿µ Àü·« ±âȹ ¾à»ç ÀÎÅÏ ¸ðÁý ¹Ù·Î°¡±â Sr. Regional Medical Advisor (MSL) ¹Ù·Î°¡±â (´ëÀü/Ãæû) ¿µ¾÷ºÎ °æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â ±¹Á¦¾àÇ°(ÁÖ) °³¹ßºÎ(ÀǾàÇ° Çмú ¾÷¹«) ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Senior Clinical Research Associate ¹Ù·Î°¡±â ¿µ¾÷ / training / compliance / admin ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ´Ù»êÁ¦¾à, 360¾ï ±Ô¸ð ¸ß½ÃÄÚ ¼öÃâ °è¾à URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ´Ù»êÁ¦¾à, 360¾ï ±Ô¸ð ¸ß½ÃÄÚ ¼öÃâ °è¾à ±â»çÀÔ·Â : 20.11.18 11:59:05 0 °¡ ÇÃÄ£Ãß°¡ Neolpharma Group°ú º»Å¼º °íÇù¾Ð¾à 2Á¾ °ø±Þ Á¦ÈÞ ÇöÁö ÀÓ»ó µî °ÅÃÄ 2022³â Ãâ½Ã Àü¸Á [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] ´Ù»êÁ¦¾àÀÌ 360¾ï ±Ô¸ð ¸ß½ÃÄÚ ¼öÃâ °è¾àÀ» ü°áÇß´Ù. 18ÀÏ È¸»ç¿¡ µû¸£¸é ´Ù»êÁ¦¾àÀº ¸ß½ÃÄÚ Neolpharma Group°ú º»Å¼º°íÇ÷¾Ð Ä¡·á¿¡ »ç¿ëµÇ´Â Ç÷¾Ð°ÇÏÁ¦ 'ÇÁ¸®ÅÙ¼ÇÇ÷¯½ºÁ¤'°ú 'Æ®À©¾×Æ®Á¤' ¼öÃâ °è¾àÀ» ¸Î¾ú´Ù. ´Ù»êÁ¦¾àÀº ÇØ´ç Á¦Ç°Àº ÇöÁö Çã°¡ÈÄ 5³â°£ Neolpharma Group¿¡ °ø±ÞÇÑ´Ù. Ãâ½Ã ½ÃÁ¡Àº ¸ß½ÃÄÚ ÇöÁö ÀÓ»ó µî Çã°¡ ÀýÂ÷¸¦ °ÅÃÄ 2022³â °æÀÌ´Ù. °è¾à ±Ý¾×Àº 3250¸¸ ´Þ·¯(360¾ï¿ø) ±Ô¸ð´Ù. Neolpharma GroupÀº ¼ø¼ö ¸ß½ÃÄÚ ÀÚº» ¼³¸³È¸»ç·Î ¸ß½ÃÄÚ Á¤ºÎ ÀÔÂû Á¶´Þ 2À§ ±â¾÷ÀÌ´Ù. ¸ß½ÃÄÚ ¿Ü ¹Ì±¹, Áß³²¹Ì ±¹°¡¸¦ ´ë»óÀ¸·Î ¼öÃâÀ» ÁøÇàÇÏ°í ÀÖ´Ù. ÁÖ»çÁ¦ »ý»ê ¼³ºñ´Â ¾Æ¸Þ¸®Ä« ´ë·ú ³» ÃÖ´ë ±Ô¸ð¸¦ º¸À¯ÇÏ°í ÀÖ´Ù. ȸ»ç °ü°èÀÚ´Â "Áß³²¹Ì ±³µÎº¸ÀÎ ¸ß½ÃÄÚ¸¦ È®º¸ÇØ µ¿³²¾Æ µî ±âÁ¸ Áö¿ª¿¡ ÀÌ¾î ¼öÃâ È®´ë°¡ ±â´ëµÈ´Ù"°í ¸»Çß´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ¢ß¾ÖÀÓ½º¹ÙÀÌ¿À»çÀ̾𽺠RA Manager ä¿ë ¹Ù·Î°¡±â RA/PV Manager (°úÀå±Þ ÀÌ»ó) ¸ðÁý ¹Ù·Î°¡±â (Sr.) Medical & Scientific Relations ¹Ù·Î°¡±â º¹»ê³ªÀ̽º ºÎ»ê°ü¸®¾à»ç (ºÎ»êÅëÇÕ¹°·ù¼¾ÅÍ) ¹Ù·Î°¡±â [±¤µ¿Á¦¾à] Ç°Áú°¨»çÆÀ Á¦Á¶°ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â [HLBÁ¦¾à] ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â ÀǾàÇ°Àç°í ÀÔÃâ°í¹× Àç°í°ü¸®»ç¿ø¸ðÁý ¹Ù·Î°¡±â [ÇÏ¿ìÅõ¾à] ºê·£µå/Ç÷§Æû ¿î¿µ Àü·« ±âȹ ¾à»ç ÀÎÅÏ ¸ðÁý ¹Ù·Î°¡±â Sr. Regional Medical Advisor (MSL) ¹Ù·Î°¡±â (´ëÀü/Ãæû) ¿µ¾÷ºÎ °æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â ±¹Á¦¾àÇ°(ÁÖ) °³¹ßºÎ(ÀǾàÇ° Çмú ¾÷¹«) ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Senior Clinical Research Associate ¹Ù·Î°¡±â ¿µ¾÷ / training / compliance / admin ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ´Ù»êÁ¦¾à, 360¾ï ±Ô¸ð ¸ß½ÃÄÚ ¼öÃâ °è¾à URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ´Ù»êÁ¦¾à, 360¾ï ±Ô¸ð ¸ß½ÃÄÚ ¼öÃâ °è¾à ±â»çÀÔ·Â : 20.11.18 11:59:05 0 °¡ ÇÃÄ£Ãß°¡ Neolpharma Group°ú º»Å¼º °íÇù¾Ð¾à 2Á¾ °ø±Þ Á¦ÈÞ ÇöÁö ÀÓ»ó µî °ÅÃÄ 2022³â Ãâ½Ã Àü¸Á [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] ´Ù»êÁ¦¾àÀÌ 360¾ï ±Ô¸ð ¸ß½ÃÄÚ ¼öÃâ °è¾àÀ» ü°áÇß´Ù. 18ÀÏ È¸»ç¿¡ µû¸£¸é ´Ù»êÁ¦¾àÀº ¸ß½ÃÄÚ Neolpharma Group°ú º»Å¼º°íÇ÷¾Ð Ä¡·á¿¡ »ç¿ëµÇ´Â Ç÷¾Ð°ÇÏÁ¦ 'ÇÁ¸®ÅÙ¼ÇÇ÷¯½ºÁ¤'°ú 'Æ®À©¾×Æ®Á¤' ¼öÃâ °è¾àÀ» ¸Î¾ú´Ù. ´Ù»êÁ¦¾àÀº ÇØ´ç Á¦Ç°Àº ÇöÁö Çã°¡ÈÄ 5³â°£ Neolpharma Group¿¡ °ø±ÞÇÑ´Ù. Ãâ½Ã ½ÃÁ¡Àº ¸ß½ÃÄÚ ÇöÁö ÀÓ»ó µî Çã°¡ ÀýÂ÷¸¦ °ÅÃÄ 2022³â °æÀÌ´Ù. °è¾à ±Ý¾×Àº 3250¸¸ ´Þ·¯(360¾ï¿ø) ±Ô¸ð´Ù. Neolpharma GroupÀº ¼ø¼ö ¸ß½ÃÄÚ ÀÚº» ¼³¸³È¸»ç·Î ¸ß½ÃÄÚ Á¤ºÎ ÀÔÂû Á¶´Þ 2À§ ±â¾÷ÀÌ´Ù. ¸ß½ÃÄÚ ¿Ü ¹Ì±¹, Áß³²¹Ì ±¹°¡¸¦ ´ë»óÀ¸·Î ¼öÃâÀ» ÁøÇàÇÏ°í ÀÖ´Ù. ÁÖ»çÁ¦ »ý»ê ¼³ºñ´Â ¾Æ¸Þ¸®Ä« ´ë·ú ³» ÃÖ´ë ±Ô¸ð¸¦ º¸À¯ÇÏ°í ÀÖ´Ù. ȸ»ç °ü°èÀÚ´Â "Áß³²¹Ì ±³µÎº¸ÀÎ ¸ß½ÃÄÚ¸¦ È®º¸ÇØ µ¿³²¾Æ µî ±âÁ¸ Áö¿ª¿¡ ÀÌ¾î ¼öÃâ È®´ë°¡ ±â´ëµÈ´Ù"°í ¸»Çß´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ´Ù»êÁ¦¾à, 360¾ï ±Ô¸ð ¸ß½ÃÄÚ ¼öÃâ °è¾à URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö